{"id":"https://openalex.org/W2088856446","doi":"https://doi.org/10.1097/01.cji.0000211333.06762.47","title":"Phase I Clinical Study With Multiple Peptide Vaccines in Combination With Tetanus Toxoid and GM-CSF in Advanced-stage HLA-A*0201-positive Melanoma Patients","display_name":"Phase I Clinical Study With Multiple Peptide Vaccines in Combination With Tetanus Toxoid and GM-CSF in Advanced-stage HLA-A*0201-positive Melanoma Patients","alternate_titles":[],"publication_year":2007,"publication_date":"2007-02-01","ids":{"openalex":"https://openalex.org/W2088856446","doi":"https://doi.org/10.1097/01.cji.0000211333.06762.47","mag":"2088856446","pmid":"https://pubmed.ncbi.nlm.nih.gov/17471170"},"language":"en","primary_location":{"id":"doi:10.1097/01.cji.0000211333.06762.47","doi":"https://doi.org/10.1097/01.cji.0000211333.06762.47","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.cji.0000211333.06762.47","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2088856446"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000857797","display_name":"Adriaan D. Bins","orcid":"https://orcid.org/0000-0002-9794-6526","observed_orcids":["https://orcid.org/0000-0002-9794-6526"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Adriaan Bins","raw_affiliation_strings":["Divisions of Immunology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands","Immunology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisions of Immunology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Immunology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001226095","display_name":"Henk A. Mallo","orcid":"https://orcid.org/0000-0001-6555-4942","observed_orcids":["https://orcid.org/0000-0001-6555-4942"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henk Mallo","raw_affiliation_strings":["Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041009869","display_name":"Johan J. Sein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Johan Sein","raw_affiliation_strings":["Clinical Chemistry, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Chemistry, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021498004","display_name":"Colette van den Bogaard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Colette van den Bogaard","raw_affiliation_strings":["Clinical Chemistry, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Chemistry, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113557752","display_name":"Willem J. Nooijen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Willem Nooijen","raw_affiliation_strings":["Clinical Chemistry, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Chemistry, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112778162","display_name":"Florry A. Vyth\u2010Dreese","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Florry Vyth-Dreese","raw_affiliation_strings":["Immunology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085958205","display_name":"Bastiaan Nuijen","orcid":"https://orcid.org/0000-0002-8652-3560","observed_orcids":["https://orcid.org/0000-0002-8652-3560"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bastiaan Nuijen","raw_affiliation_strings":["Pharmacy, Slotervaart Hospital, Louwesweg 6, 1066 EC, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy, Slotervaart Hospital, Louwesweg 6, 1066 EC, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802065108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113694441","display_name":"G. C. DE GAST","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gijsbert C. de Gast","raw_affiliation_strings":["Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017136846","display_name":"John B.A.G. Haanen","orcid":"https://orcid.org/0000-0001-5884-7704","observed_orcids":["https://orcid.org/0000-0001-5884-7704"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"John B. A. G. Haanen","raw_affiliation_strings":["Immunology","Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology","institution_ids":[]},{"raw_affiliation_string":"Medical Oncology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5000857797","https://openalex.org/A5017136846","https://openalex.org/A5112778162"],"corresponding_institution_ids":["https://openalex.org/I2898336195"],"apc_list":null,"apc_paid":null,"fwci":1.1978,"has_fulltext":false,"cited_by_count":26,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.76655256,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"30","issue":"2","first_page":"234","last_page":"239"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peptide-vaccination","display_name":"peptide vaccination","score":0.7450000047683716},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8040000200271606},{"id":"https://openalex.org/keywords/hla-a-0201","display_name":"HLA-A*0201","score":0.8629999756813049},{"id":"https://openalex.org/keywords/melan-a","display_name":"Melan-A","score":0.6909999847412109},{"id":"https://openalex.org/keywords/tyrosinase","display_name":"tyrosinase","score":0.9760000109672546},{"id":"https://openalex.org/keywords/gp100","display_name":"gp100","score":1.0},{"id":"https://openalex.org/keywords/tetanus-toxoid","display_name":"tetanus toxoid","score":0.9700000286102295},{"id":"https://openalex.org/keywords/gm-csf","display_name":"GM-CSF","score":0.9789999723434448},{"id":"https://openalex.org/keywords/intradermal-vaccination","display_name":"intradermal vaccination","score":0.6660000085830688},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8650000095367432},{"id":"https://openalex.org/keywords/tumor-specific-t-cells","display_name":"tumor-specific T cells","score":0.7250000238418579},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8140000104904175},{"id":"https://openalex.org/keywords/vaccine-toxicity","display_name":"vaccine toxicity","score":0.49399998784065247},{"id":"https://openalex.org/keywords/advanced-melanoma","display_name":"advanced melanoma","score":0.703000009059906},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.796999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7575809359550476},{"id":"https://openalex.org/C2777351567","wikidata":"https://www.wikidata.org/wiki/Q908822","display_name":"Toxoid","level":4,"score":0.7267270088195801},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.6578076481819153},{"id":"https://openalex.org/C2779841045","wikidata":"https://www.wikidata.org/wiki/Q47790","display_name":"Tetanus","level":3,"score":0.6479635238647461},{"id":"https://openalex.org/C2776789287","wikidata":"https://www.wikidata.org/wiki/Q7166532","display_name":"Peptide vaccine","level":4,"score":0.5910956859588623},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.531568169593811},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.47723034024238586},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4282534718513489},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4103759527206421},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.39582139253616333},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.37854209542274475},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3392406105995178},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.1115679144859314},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005134","descriptor_name":"Eye Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005134","descriptor_name":"Eye Neoplasms","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013745","descriptor_name":"Tetanus Toxoid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014611","descriptor_name":"Vaccination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015234","descriptor_name":"HLA-A Antigens","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D015789","descriptor_name":"HLA-A2 Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016178","descriptor_name":"Granulocyte-Macrophage Colony-Stimulating Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D022223","descriptor_name":"Vaccines, Subunit","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D022223","descriptor_name":"Vaccines, Subunit","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.cji.0000211333.06762.47","doi":"https://doi.org/10.1097/01.cji.0000211333.06762.47","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.cji.0000211333.06762.47","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},{"id":"pmid:17471170","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17471170","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunotherapy (Hagerstown, Md. : 1997)","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1521600055","https://openalex.org/W1522781268","https://openalex.org/W1588193878","https://openalex.org/W1928212615","https://openalex.org/W1982752226","https://openalex.org/W1983737583","https://openalex.org/W1983806918","https://openalex.org/W1991287153","https://openalex.org/W1992405332","https://openalex.org/W1992699637","https://openalex.org/W2011653164","https://openalex.org/W2012148175","https://openalex.org/W2031172509","https://openalex.org/W2031908218","https://openalex.org/W2036961863","https://openalex.org/W2037661067","https://openalex.org/W2046407551","https://openalex.org/W2049360002","https://openalex.org/W2050219665","https://openalex.org/W2108909957","https://openalex.org/W2112607009","https://openalex.org/W2115439647","https://openalex.org/W2127046686","https://openalex.org/W2128670378","https://openalex.org/W2138873514","https://openalex.org/W2144304036","https://openalex.org/W2151246207","https://openalex.org/W2153746213","https://openalex.org/W2166370041","https://openalex.org/W2269774696"],"related_works":["https://openalex.org/W2140147891","https://openalex.org/W2009402217","https://openalex.org/W2164584613","https://openalex.org/W2031908218","https://openalex.org/W2062954284","https://openalex.org/W2589392157","https://openalex.org/W1986019318","https://openalex.org/W2265735771","https://openalex.org/W2162807322","https://openalex.org/W2052626082"],"abstract_inverted_index":{"Successful":[0],"induction":[1],"of":[2,110,114,173],"functional":[3],"tumor-specific":[4],"T":[5],"cells":[6,123],"by":[7,169],"peptide":[8,63,212,223],"vaccination":[9,213,224],"in":[10,15,23,86,90,119,164,167,184,225,236],"animal":[11],"models":[12],"has":[13],"resulted":[14],"many":[16],"clinical":[17,31,197],"trials":[18],"to":[19,74,180,218],"test":[20],"this":[21,28,189],"approach":[22],"advanced-stage":[24,237],"melanoma":[25,35,234],"patients.":[26,238],"In":[27,99,144,207],"phase":[29,195],"I":[30,196],"trial,":[32,198],"11":[33,175],"end-stage":[34],"patients":[36,81,93,176],"were":[37,97],"vaccinated":[38],"intradermally":[39],"with":[40,54,130,209],"3":[41,92],"peptides:":[42],"MART-1(26-35)":[43,107],"E27L":[44],"(ELAGIGILTV),":[45],"tyrosinase(368-376)":[46],"N375Q":[47],"(YMDGTMSQV),":[48],"and":[49,57,72,108,112],"gp100(209-217)":[50],"T210M":[51],"(IMQVPFSV),":[52],"admixed":[53],"tetanus":[55],"toxoid":[56],"granulocyte-monocyte":[58],"colony":[59],"stimulating":[60],"factor.":[61],"The":[62,134],"vaccine":[64],"was":[65,104,153,156,161,202,204],"well":[66],"tolerated":[67],"at":[68],"all":[69,80],"tested":[70],"doses,":[71],"led":[73],"grade":[75],"1-2":[76],"toxicity":[77],"only.":[78],"Although":[79,188],"did":[82,124],"show":[83],"a":[84,138,145,148,192],"rise":[85],"antitetanus":[87],"IgG":[88],"titers,":[89],"only":[91],"peptide-specific":[94],"CD8":[95,116],"T-cells":[96],"induced.":[98],"2":[100],"cases,":[101],"the":[102,115,131,170,174,199,219],"response":[103,141,151,181],"directed":[105],"against":[106,142],"consisted":[109],"0.2%":[111],"3.3%":[113],"population;":[117],"however,":[118],"both":[120],"instances":[121],"these":[122,215],"not":[125,162,228],"produce":[126],"interferon-gamma":[127],"on":[128],"stimulation":[129],"unmodified":[132],"peptide.":[133],"third":[135],"patient":[136],"mounted":[137],"small":[139,193],"(0.1%)":[140],"gp100.":[143],"fourth":[146],"patient,":[147],"nonfunctional":[149],"tyrosinase-specific":[150],"(0.6%)":[152],"found":[154],"that":[155,201,222],"present":[157],"before":[158],"vaccination,":[159],"but":[160],"affected":[163],"size":[165],"nor":[166],"function":[168],"vaccine.":[171],"None":[172],"responded":[177],"clinically":[178],"according":[179],"evaluation":[182],"criteria":[183],"solid":[185],"tumors":[186],"criteria.":[187],"study":[190],"is":[191,227],"scale":[194],"efficacy":[200],"observed":[203],"disappointingly":[205],"low.":[206],"accordance":[208],"previously":[210],"published":[211],"studies,":[214],"results":[216],"add":[217],"increasing":[220],"evidence":[221],"itself":[226],"potent":[229],"enough":[230],"as":[231],"an":[232],"effective":[233],"immunotherapy":[235]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2088856446","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
